VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Tuesday, December 30, 2025
Stock Comparison
Pernod Ricard SA vs Sanofi
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Pernod Ricard SA
RI · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Pernod Ricard SA's moat claims, evidence, and risks.
View RI analysisSanofi
SAN · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Pernod Ricard SA leads (75 / 100 vs 74 / 100 for Sanofi).
- Segment focus: Pernod Ricard SA has 3 segments (42.3% in Asia/Rest of the World); Sanofi has 3 segments (79.8% in Pharma (Prescription Medicines)).
- Moat breadth: Pernod Ricard SA has 4 moat types across 2 domains; Sanofi has 5 across 3.
Primary market context
Pernod Ricard SA
Asia/Rest of the World
Premium spirits brand ownership, marketing, and distribution
Asia-Pacific, Africa, and other emerging markets
On-trade, off-trade, distributors, and duty-free operators
Brand owner and local-market route-to-market operator
42.3%
Sanofi
Pharma (Prescription Medicines)
Branded prescription pharmaceuticals (immunology, rare disease, neurology, oncology, general medicines)
Global
Patients via payers/providers and channel partners (wholesalers, pharmacies, hospitals)
Research-based drug developer, manufacturer, and marketer
79.8%
Side-by-side metrics
Moat coverage
Shared moat types
Pernod Ricard SA strengths
Sanofi strengths
Segment mix
Pernod Ricard SA segments
Full profile >Europe
Oligopoly
Americas
Oligopoly
Asia/Rest of the World
Oligopoly
Sanofi segments
Full profile >Pharma (Prescription Medicines)
Oligopoly
Vaccines
Oligopoly
Opella (Consumer Healthcare - Sanofi minority stake)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.